The WHO pointers encourage the adoption of such technologies, provided they can be validated to exhibit equal or top-quality overall performance compared to standard methods.Manufacturers seeking to put into practice these solutions will have to provide robust validation knowledge to exhibit their equivalence to pharmacopoeial strategies.The fatigu